Gynecological Endocrinology · 2005 · 26 citations · 24 references
MedicineOncologyPharmacotherapyEndocrine PharmacotherapyReproductive EndocrinologyReproductive MedicineGonadal HormonesGynecologic EndocrinologyHormonal Cancer TherapyHormonal TherapyOvarian FunctionOvarian PhysiologyGnrh Agonist Ovarian SuppressionGnrh AgonistsGonadotropin-releasing Hormone Agonist TherapyGonadotropin-releasing Hormone PharmacologyInhibin BPremature Ovarian FailurePremature Ovarian Insufficiency TreatmentSerum Follicle-stimulating Hormone
OBJECTIVE: To explore the effects of a gonadotropin-releasing hormone (GnRH) agonist depot (goserelin acetate) in women with Hodgkin's disease receiving chemotherapy while taking a continuous combined estrogen-progestin preparation as add-back on the prevention of premature ovarian failure (POF). METHODS: In a prospective pilot study, five premenopausal women with Hodgkin's disease received a GnRH agonist depot plus add-back until polychemotherapy was completed. Every 4 weeks during treatment and thereafter, a hormonal profile (follicle-stimulating hormone (FSH), luteinizing hormone, 17beta-estradiol, progesterone and inhibin B) was measured until resumption of menstruation or the development of a hypergonadotropic state (2 x FSH > 30 U/l). RESULTS: All patients reached prepubertal status during treatment. After discontinuation of goserelin acetate, one patient developed a hypergonadotropic state and four patients resumed menstruation. One of those patients became pregnant and delivered a healthy son. CONCLUSIONS: The effectiveness of GnRH agonist plus add-back on the prevention of POF during polychemotherapy in women with Hodgkin's disease needs further elucidation in randomized controlled trials. The results of our pilot study are promising.
24
Cyclophosphamide-Induced Ovarian Failure
Garry L. Warne, K. F. Fairley, J. B. Hobbs et al. · New England Journal of Medicine · 1973 · 415 citations
Medicine, Endocrinology, Gynecology +13
Female Reproductive Potential after Treatment for Hodgkin's Disease
Sandra J. Horning, Richard T. Hoppe, Henry S. Kaplan et al. · New England Journal of Medicine · 1981 · 375 citations
IMMUNE-COMPLEX GLOMERULOPATHY IN PATIENTS TREATED WITH CAPTOPRIL
StevenJ. Hoorntje, J. J. Weening, Tjwanh. The et al. · The Lancet · 1980 · 308 citations
Medicine, Immunology, Nephrology +10
The Relationship of Gonadal Activity and Chemotherapy-Induced Gonadal Damage
Scott A. Rivkees · JAMA · 1988 · 296 citations
Medicine, Oncology, Pharmacology +13
Cytotoxic-lnduced Ovarian Failure in Women With Hodgkin's Disease
Ramona M. Chapman · JAMA · 1979 · 287 citations
Medicine, Gynecology, Oncology +12